Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase
In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The...
Gespeichert in:
Veröffentlicht in: | Archiv der Pharmazie (Weinheim) 2003-03, Vol.336 (1), p.31-38 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 38 |
---|---|
container_issue | 1 |
container_start_page | 31 |
container_title | Archiv der Pharmazie (Weinheim) |
container_volume | 336 |
creator | Baston, Eckhard Salem, Ola I. A. Hartmann, Rolf W. |
description | In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The principal synthetic approach for the desired compounds consisted of a Wittig olefination between 1, 4‐dioxaspiro [4.5]‐decane‐8‐carbaldehyde (4g and the appropriate phosphonium salts. The compounds were tested for inhibition of human 5α reductase isozymes 1 and 2 using DU 145 cells and preparations from prostatic tissue, respectively. They turned out to be good inhibitors of the prostatic isozyme 2 with compound 1 being the most potent one (IC50 = 760 nM). Isozyme 1 was only slightly inhibited. It is concluded that the novel structures are appropriate for being further optimized, aiming at the development of a novel drug for the treatment of benign prostatic hyperplasia. |
doi_str_mv | 10.1002/ardp.200390001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73143313</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73143313</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4491-a1d11a14e55eae7c42670fdab42811f32db4462de39bb7ef91b3acfd29224c5a3</originalsourceid><addsrcrecordid>eNqFkE1vEzEQhi0EoqFw5Yh8gdsGjz92u9zSUJqiqqDyebO89iwxOOtg75bkZ_FH-E1slKjlxmmk0fO-M3oIeQpsCozxlya59ZQzJmrGGNwjE1AcCgkn8j6ZMFGqouRCHJFHOX8fCcG4ekiOgJdlyRVMSJxvbYhL3BRQYId0blITN9vgLZ1Z7_Ir-mHb9UvMPlPTOXrqY4jfvDWBnt2YMJjex47Gll7FGwz0olv6xvcx5d1uMaxMR9Wf3_Qa3WB7k_ExedCakPHJYR6TT2_OPs4XxeW784v57LKwUtZQGHAABiQqhQYrK3lZsdaZRvITgFZw10hZcoeibpoK2xoaYWzreM25tMqIY_Ji37tO8eeAudcrny2GYDqMQ9aVACkEiBGc7kGbYs4JW71OfmXSVgPTO8V6p1jfKh4Dzw7NQ7NCd4cfnI7A8wNg8uipTaazPt9xslRMsnrk6j33ywfc_uesnl2_fv_vE8U-63OPm9usST90WYlK6S9X51ou2Ff29nOlpfgLpoulHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73143313</pqid></control><display><type>article</type><title>Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Baston, Eckhard ; Salem, Ola I. A. ; Hartmann, Rolf W.</creator><creatorcontrib>Baston, Eckhard ; Salem, Ola I. A. ; Hartmann, Rolf W.</creatorcontrib><description>In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The principal synthetic approach for the desired compounds consisted of a Wittig olefination between 1, 4‐dioxaspiro [4.5]‐decane‐8‐carbaldehyde (4g and the appropriate phosphonium salts. The compounds were tested for inhibition of human 5α reductase isozymes 1 and 2 using DU 145 cells and preparations from prostatic tissue, respectively. They turned out to be good inhibitors of the prostatic isozyme 2 with compound 1 being the most potent one (IC50 = 760 nM). Isozyme 1 was only slightly inhibited. It is concluded that the novel structures are appropriate for being further optimized, aiming at the development of a novel drug for the treatment of benign prostatic hyperplasia.</description><identifier>ISSN: 0365-6233</identifier><identifier>EISSN: 1521-4184</identifier><identifier>DOI: 10.1002/ardp.200390001</identifier><identifier>PMID: 12666251</identifier><identifier>CODEN: ARPMAS</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>5-alpha Reductase Inhibitors ; Benign prostatic hyperplasia ; Biological and medical sciences ; Carboxylic Acids - chemical synthesis ; Carboxylic Acids - chemistry ; Carboxylic Acids - pharmacology ; Chromatography, High Pressure Liquid ; Cyclohex-1-ene carboxylic acids ; DU 145 cells ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Humans ; Isoenzymes - drug effects ; Isozymes 1 and 2 ; Male ; Medical sciences ; Nonsteroidal inhibitors ; Pharmacology. Drug treatments ; Steroid 5α reductase ; Steroidomimetics ; Structure-Activity Relationship ; Urinary system</subject><ispartof>Archiv der Pharmazie (Weinheim), 2003-03, Vol.336 (1), p.31-38</ispartof><rights>2003 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4491-a1d11a14e55eae7c42670fdab42811f32db4462de39bb7ef91b3acfd29224c5a3</citedby><cites>FETCH-LOGICAL-c4491-a1d11a14e55eae7c42670fdab42811f32db4462de39bb7ef91b3acfd29224c5a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fardp.200390001$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fardp.200390001$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14650409$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12666251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baston, Eckhard</creatorcontrib><creatorcontrib>Salem, Ola I. A.</creatorcontrib><creatorcontrib>Hartmann, Rolf W.</creatorcontrib><title>Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase</title><title>Archiv der Pharmazie (Weinheim)</title><addtitle>Arch. Pharm. Pharm. Med. Chem</addtitle><description>In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The principal synthetic approach for the desired compounds consisted of a Wittig olefination between 1, 4‐dioxaspiro [4.5]‐decane‐8‐carbaldehyde (4g and the appropriate phosphonium salts. The compounds were tested for inhibition of human 5α reductase isozymes 1 and 2 using DU 145 cells and preparations from prostatic tissue, respectively. They turned out to be good inhibitors of the prostatic isozyme 2 with compound 1 being the most potent one (IC50 = 760 nM). Isozyme 1 was only slightly inhibited. It is concluded that the novel structures are appropriate for being further optimized, aiming at the development of a novel drug for the treatment of benign prostatic hyperplasia.</description><subject>5-alpha Reductase Inhibitors</subject><subject>Benign prostatic hyperplasia</subject><subject>Biological and medical sciences</subject><subject>Carboxylic Acids - chemical synthesis</subject><subject>Carboxylic Acids - chemistry</subject><subject>Carboxylic Acids - pharmacology</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cyclohex-1-ene carboxylic acids</subject><subject>DU 145 cells</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Isoenzymes - drug effects</subject><subject>Isozymes 1 and 2</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nonsteroidal inhibitors</subject><subject>Pharmacology. Drug treatments</subject><subject>Steroid 5α reductase</subject><subject>Steroidomimetics</subject><subject>Structure-Activity Relationship</subject><subject>Urinary system</subject><issn>0365-6233</issn><issn>1521-4184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1vEzEQhi0EoqFw5Yh8gdsGjz92u9zSUJqiqqDyebO89iwxOOtg75bkZ_FH-E1slKjlxmmk0fO-M3oIeQpsCozxlya59ZQzJmrGGNwjE1AcCgkn8j6ZMFGqouRCHJFHOX8fCcG4ekiOgJdlyRVMSJxvbYhL3BRQYId0blITN9vgLZ1Z7_Ir-mHb9UvMPlPTOXrqY4jfvDWBnt2YMJjex47Gll7FGwz0olv6xvcx5d1uMaxMR9Wf3_Qa3WB7k_ExedCakPHJYR6TT2_OPs4XxeW784v57LKwUtZQGHAABiQqhQYrK3lZsdaZRvITgFZw10hZcoeibpoK2xoaYWzreM25tMqIY_Ji37tO8eeAudcrny2GYDqMQ9aVACkEiBGc7kGbYs4JW71OfmXSVgPTO8V6p1jfKh4Dzw7NQ7NCd4cfnI7A8wNg8uipTaazPt9xslRMsnrk6j33ywfc_uesnl2_fv_vE8U-63OPm9usST90WYlK6S9X51ou2Ff29nOlpfgLpoulHg</recordid><startdate>200303</startdate><enddate>200303</enddate><creator>Baston, Eckhard</creator><creator>Salem, Ola I. A.</creator><creator>Hartmann, Rolf W.</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley-VCH</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200303</creationdate><title>Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase</title><author>Baston, Eckhard ; Salem, Ola I. A. ; Hartmann, Rolf W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4491-a1d11a14e55eae7c42670fdab42811f32db4462de39bb7ef91b3acfd29224c5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>5-alpha Reductase Inhibitors</topic><topic>Benign prostatic hyperplasia</topic><topic>Biological and medical sciences</topic><topic>Carboxylic Acids - chemical synthesis</topic><topic>Carboxylic Acids - chemistry</topic><topic>Carboxylic Acids - pharmacology</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cyclohex-1-ene carboxylic acids</topic><topic>DU 145 cells</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Isoenzymes - drug effects</topic><topic>Isozymes 1 and 2</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nonsteroidal inhibitors</topic><topic>Pharmacology. Drug treatments</topic><topic>Steroid 5α reductase</topic><topic>Steroidomimetics</topic><topic>Structure-Activity Relationship</topic><topic>Urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baston, Eckhard</creatorcontrib><creatorcontrib>Salem, Ola I. A.</creatorcontrib><creatorcontrib>Hartmann, Rolf W.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archiv der Pharmazie (Weinheim)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baston, Eckhard</au><au>Salem, Ola I. A.</au><au>Hartmann, Rolf W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase</atitle><jtitle>Archiv der Pharmazie (Weinheim)</jtitle><addtitle>Arch. Pharm. Pharm. Med. Chem</addtitle><date>2003-03</date><risdate>2003</risdate><volume>336</volume><issue>1</issue><spage>31</spage><epage>38</epage><pages>31-38</pages><issn>0365-6233</issn><eissn>1521-4184</eissn><coden>ARPMAS</coden><abstract>In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The principal synthetic approach for the desired compounds consisted of a Wittig olefination between 1, 4‐dioxaspiro [4.5]‐decane‐8‐carbaldehyde (4g and the appropriate phosphonium salts. The compounds were tested for inhibition of human 5α reductase isozymes 1 and 2 using DU 145 cells and preparations from prostatic tissue, respectively. They turned out to be good inhibitors of the prostatic isozyme 2 with compound 1 being the most potent one (IC50 = 760 nM). Isozyme 1 was only slightly inhibited. It is concluded that the novel structures are appropriate for being further optimized, aiming at the development of a novel drug for the treatment of benign prostatic hyperplasia.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>12666251</pmid><doi>10.1002/ardp.200390001</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0365-6233 |
ispartof | Archiv der Pharmazie (Weinheim), 2003-03, Vol.336 (1), p.31-38 |
issn | 0365-6233 1521-4184 |
language | eng |
recordid | cdi_proquest_miscellaneous_73143313 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | 5-alpha Reductase Inhibitors Benign prostatic hyperplasia Biological and medical sciences Carboxylic Acids - chemical synthesis Carboxylic Acids - chemistry Carboxylic Acids - pharmacology Chromatography, High Pressure Liquid Cyclohex-1-ene carboxylic acids DU 145 cells Enzyme Inhibitors - chemical synthesis Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacology Humans Isoenzymes - drug effects Isozymes 1 and 2 Male Medical sciences Nonsteroidal inhibitors Pharmacology. Drug treatments Steroid 5α reductase Steroidomimetics Structure-Activity Relationship Urinary system |
title | Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A34%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclohex-1-ene%20Carboxylic%20Acids:%20Synthesis%20and%20Biological%20Evaluation%20of%20Novel%20Inhibitors%20of%20Human%205%CE%B1%20Reductase&rft.jtitle=Archiv%20der%20Pharmazie%20(Weinheim)&rft.au=Baston,%20Eckhard&rft.date=2003-03&rft.volume=336&rft.issue=1&rft.spage=31&rft.epage=38&rft.pages=31-38&rft.issn=0365-6233&rft.eissn=1521-4184&rft.coden=ARPMAS&rft_id=info:doi/10.1002/ardp.200390001&rft_dat=%3Cproquest_cross%3E73143313%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73143313&rft_id=info:pmid/12666251&rfr_iscdi=true |